Generate a tailored SOP for Dr. Mary Rinella. Improve your application with a focused, well-structured draft.
Mary E. Rinella, MD, is a Professor in the Biological Sciences Division at the University of Chicago, specializing in Medicine, Gastroenterology, and Hepatology. Since January 2021, she has served as the director of the Metabolic Fatty Liver Program and Clinical Trials Section. Dr. Rinella has held prominent leadership roles, including membership on the Governing Board of the American Association for the Study of Liver Disease (AASLD), where she has been a lead author on clinical practice guidance regarding the diagnosis and management of non-alcoholic fatty liver disease (NAFLD) and metabolic dysfunction-associated steatotic liver disease (MASLD). She has been instrumental in revising the nomenclature for NAFLD and has chaired AASLD task forces focused on increasing disease awareness and improving patient care outcomes. Dr. Rinella's clinical research primarily focuses on metabolic liver diseases, with specific expertise in cholestatic liver conditions, including primary biliary cholangitis, primary sclerosing cholangitis, and autoimmune liver disease. Her approach combines multidisciplinary care with individualized strategies to help patients access the latest therapies through clinical trials.
Department of Philosophy